People with metabolic syndrome who follow intermittent fasting see a tiny but real drop in their triglyceride levels, which means their body is handling fat better.
Scientific Claim
Intermittent fasting reduces triglycerides by 0.04 mmol/L in adults with metabolic syndrome over interventions averaging 3 months, indicating a small but statistically significant improvement in fat metabolism.
Original Statement
“triglyceride level by 0.04 mmol/L (95% CIs: −0.15; −0.07)”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The effect is statistically significant and derived from RCTs. The claim accurately reflects the reported effect size and direction.
Evidence from Studies
Supporting (1)
Unknown Title
This study found that people with metabolic syndrome who tried intermittent fasting lowered their triglycerides by exactly 0.04 mmol/L — a small but real improvement — which matches the claim perfectly.